What is the ANG Lifesciences India Ltd share price today?

The share price of BSE:ANG-T on 07 Sep 2026 (as of 11:00:37 IST) is ₹34.77.

What is the BSE:ANG-T 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the BSE:ANG-T 52 week high low range shows a high of ₹49.69 and a low of ₹17.63.

What is the ANG Lifesciences India Ltd market cap?

As on 07 Sep 2026, ANG Lifesciences India Ltd market cap is ₹44.52 Cr.

What is the shareholding pattern of ANG Lifesciences India Ltd Stock?

The shareholding pattern of ANG Lifesciences India Ltd, as of last reported-on 31 Mar 2026 is: Promoters: 70.60% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 29.40% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of ANG Lifesciences India Ltd?

The Price-to-Earnings (PE) ratio of ANG Lifesciences India Ltd is 0, and the Price-to-Book (PB) ratio is 0.46, as on 07 Sep 2026.

ANG Lifesciences India Share Price

39.49+0.00 (+1.99%)

+9.97% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+1.99%

1 Week

+4.00%

1 Month

+41.44%

3 Month

-7.80%

6 Month

+104.51%

YTD

+33.64%

1 Year

+9.97%

5 Year

-88.84%

10 Year

Max

+34.32%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

39.39

37.97

27.00

23.13

17.63

High

39.49

43.99

49.69

About

ANG Lifesciences India is ISO-9001:2008 certified and has the modern & sophisticated plant equipments technique and manpower. The planning and construction of plant has been done to conform to the Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMA-ANSE

DIVISLAB-ANSE

TORNTPHARM-ANSE

ZYDUSLIFE-ANSE

CIPLA-ANSE

LAURUSLABS-ANSE

MANKIND-ANSE

DRREDDY-ANSE

AUROPHARMA-ANSE

LUPIN-ANSE

ANG-TNSE

LTP

1W Low

1W High

Market cap (₹)

1853+17.5 (0.95%)

1835.50

1890.40

4,47,476Cr

9613+246 (2.63%)

9305.95

9739.85

2,54,764Cr

4935+130.75 (2.72%)

4864.80

5010

1,89,423Cr

1180+27 (2.34%)

1152

1191

1,16,658Cr

1404+32.55 (2.37%)

1364

1418.70

1,11,484Cr

2026.25+71 (3.63%)

1964.50

2054.55

1,09,943Cr

2475+157 (6.77%)

2302.30

2503.20

1,01,712Cr

1200.4+29.3 (2.50%)

1186.20

1221.60

1,01,005Cr

1720-15 (-0.86%)

1690

1739.60

99,253Cr

2098-46.7 (-2.18%)

2084.50

2129.85

96,031Cr

39.49+1.52 (4.00%)

37.97

39.49

51Cr

ANG Lifesciences India Share Price

39.49+0.00 (+1.99%)

+9.97% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-36%

Last year-36%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-22%

Stock Price CAGR

10 years-

5 years-36%

3 years-19%

1 year10%

Return on Equity

10 years4%

5 years4%

3 years-10%

Last year-18%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-36%	-36%
-	-	-	-22%
-	-36%	-19%	10%
4%	4%	-10%	-18%

Peer Comparison

Symbol

SUNPHARMA-A

DIVISLAB-A

TORNTPHARM-A

ZYDUSLIFE-A

CIPLA-A

LAURUSLABS-A

MANKIND-A

DRREDDY-A

AUROPHARMA-A

LUPIN-A

ANG-T

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,853	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,613	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,935	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,180	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,404	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,026.25	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,475	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.4	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,720	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,098	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
39.49	₹51 Cr	—	-3.25	-5.38	-₹11 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Trade Payables

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023	Mar 2022
—	—	—	—
₹13 Cr	₹13 Cr	₹13 Cr	₹10 Cr
₹51 Cr	₹63 Cr	₹73 Cr	₹73 Cr
₹51 Cr	₹63 Cr	₹73 Cr	₹73 Cr
₹64 Cr	₹76 Cr	₹86 Cr	₹84 Cr
₹8 Cr	₹13 Cr	₹17 Cr	₹21 Cr
₹10 Cr	₹1 Cr	₹1 Cr	₹84 L
-₹6 Cr	-₹3 Cr	-₹3 Cr	-₹4 Cr
₹2 Cr	₹3 Cr	₹6 Cr	₹15 Cr
₹0	₹2 Cr	₹2 Cr	₹2 Cr
₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr
₹16 Cr	₹17 Cr	₹25 Cr	₹37 Cr
—	—	—	—
₹66 Cr	₹66 Cr	₹68 Cr	₹71 Cr
₹21 Cr	₹24 Cr	₹31 Cr	₹30 Cr
₹56 Cr	₹50 Cr	₹45 Cr	₹47 Cr
₹28 L	₹4 Cr	₹18 Cr	₹19 Cr
₹143 Cr	₹145 Cr	₹162 Cr	₹166 Cr
₹223 Cr	₹238 Cr	₹274 Cr	₹287 Cr
₹4 Cr	₹16 Cr	₹17 Cr	₹20 Cr
₹80 Cr	₹69 Cr	₹68 Cr	₹77 Cr
—	—	—	—
₹126 Cr	₹121 Cr	₹147 Cr	₹142 Cr
₹69 Cr	₹62 Cr	₹59 Cr	₹49 Cr
₹57 Cr	₹58 Cr	₹88 Cr	₹93 Cr
₹3 L	₹3 L	₹3 L	₹3 L
₹3 L	₹3 L	₹3 L	₹3 L
₹66 L	₹62 L	₹52 L	₹41 L
₹0	₹0	₹0	₹88 L
₹58 Cr	₹59 Cr	₹89 Cr	₹94 Cr
—	—	—	—
₹54 Cr	₹48 Cr	₹48 Cr	₹37 Cr
₹67 Cr	₹73 Cr	₹83 Cr	₹102 Cr
₹4 Cr	₹6 Cr	₹6 Cr	₹7 Cr
₹1 Cr	₹1 Cr	₹2 Cr	₹1 Cr
₹36 Cr	₹46 Cr	₹43 Cr	₹46 Cr
₹161 Cr	₹173 Cr	₹183 Cr	₹193 Cr
₹18 Cr	₹29 Cr	₹21 Cr	₹27 Cr
₹223 Cr	₹238 Cr	₹274 Cr	₹287 Cr
₹49	₹58	₹66	₹81
₹49	₹58	₹66	₹65

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023	Mar 2022
-₹16 Cr	-₹11 Cr	₹3 Cr	₹54 Cr
₹13 Cr	₹20 Cr	₹21 Cr	₹17 Cr
₹6 Cr	-₹5 Cr	₹7 Cr	-₹45 Cr
₹4 Cr	₹4 Cr	₹30 Cr	₹25 Cr
-₹26 L	-₹9 Cr	₹26 Cr	₹25 Cr
-₹2 Cr	₹20 Cr	-₹9 Cr	-₹44 Cr
₹2 Cr	-₹10 Cr	-₹17 Cr	₹20 Cr
-₹16 L	-₹57,000	-₹2 L	₹23 L
₹32 L	₹32 L	₹35 L	₹11 L
₹16 L	₹32 L	₹32 L	₹35 L

Fundamental Ratios

Consolidated

Standalone

ANG Lifesciences India Share Price

39.49+0.00 (+1.99%)

+9.97% past 1 Year

Shareholding summary

Promoters

70.6%

FII

DII

Others

29.4%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
70.60%	70.60%	70.60%	70.60%	70.60%	70.60%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
29.40%	29.40%	29.40%	29.40%	29.40%	29.40%

Bulk & block deals

Name

Chauhan Trishul Jitusinh

Alpha Leon Enterprises Llp

Ways Vinimay Private Limited

Sanjay Popatlal Jain

Leena Sachin Shetty

Sundeep Arjun Karna Huf

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
03 Jan 2024	Purchase	69.37 L	₹81.93	84.67 K	Bulk	0.648423	BSE
03 Jan 2024	Sell	70.47 L	₹83.23	84.67 K	Bulk	0.648423	BSE
12 Nov 2021	Purchase	3.57 Cr	₹621	57.48 K	Bulk	0.44021	BSE
12 Nov 2021	Sell	74.05 L	₹677.77	10.93 K	Bulk	0.083671	BSE
30 Sep 2021	Sell	1.12 Cr	₹349.55	32 K	Bulk	0.245055	BSE
05 Aug 2021	Sell	1.12 Cr	₹370.05	30.40 K	Bulk	0.232802	BSE
02 Aug 2021	Sell	1.70 Cr	₹331.25	51.20 K	Bulk	0.392088	BSE
28 Jul 2021	Purchase	1.54 Cr	₹282.64	54.40 K	Bulk	0.416593	BSE
14 Jul 2021	Purchase	64.61 L	₹183.55	35.20 K	Bulk	0.26956	BSE
02 Jul 2021	Sell	52.43 L	₹109.22	48 K	Bulk	0.367582	BSE

Insider trading & SAST

Client name

Rajesh Gupta

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
16 Jun 2022	Promoter	Acquisition	0.01	70.95	—	1 K	13 Jun 2022	Market	73,55,630	SAST	29(2)	—
04 Mar 2022	Promoter	Acquisition	0.03	70.95	—	3.20 K	02 Mar 2022	Market	73,54,630	SAST	29(2)	—
01 Mar 2022	Promoter	Acquisition	0.02	70.91	—	2 K	24 Feb 2022	Market	73,51,430	SAST	29(2)	—

ANG Lifesciences India Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

ANG Lifesciences India Share Price

ANG Lifesciences India Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

ANG Lifesciences India Share Price

ANG Lifesciences India Share Price

Oscillators

Moving averages

ANG Lifesciences India Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

ANG Lifesciences India Share Price

Corporate Actions

Company details

ANG Lifesciences India Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

ANG Lifesciences India Share Price

News

ANG Lifesciences reports Profit after tax of 1.10 Crores, in the March 2026 quarter

ANG Lifesciences reports Profit after tax of Rs -4.24 Crores, in the December 2025 quarter

ANG Lifesciences India informs about confirmation certificate

ANG Lifesciences reports Profit after tax of Rs -80.10 Lakhs, in the September 2025 quarter

ANG Lifesciences - Quaterly Results

ANG Lifesciences reports Profit after tax of Rs -78.70 Lakhs, in the June 2025 quarter

ANG Lifesciences - Quaterly Results

ANG Lifesciences India informs about compliance certificate

ANG Lifesciences India informs about trading window closure

ANG Lifesciences reports Profit after tax of Rs -1.94 Crores, in the March 2025 quarter

ANG Lifesciences informs about not applicability of large corporate entity

ANG Lifesciences reports Profit after tax of Rs -4.56 Crores, in the December 2024 quarter

ANG Lifesciences - Quaterly Results

ANG Lifesciences reports Profit after tax of Rs -1.07 Crores, in the September 2024 quarter

ANG Lifesciences India informs about trading window closure

ANG Lifesciences reports Profit after tax of Rs -2.77 Crores, in the June 2024 quarter

ANG Lifesciences - Quaterly Results

ANG Lifesciences India informs about closure of trading window

ANG Lifesciences reports Profit after tax of Rs -3.60 Crores, in the March 2024 quarter

ANG Lifesciences - Quaterly Results

ANG Lifesciences India Ltd Share Price Today

ANG Lifesciences India Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator